Chandan Healthcare Ltd
Incorporated in September 2003, Chandan Healthcare Limited runs diagnostic centers in North India with pathology and radiology testing services.[1]
- Market Cap ₹ 640 Cr.
- Current Price ₹ 262
- High / Low ₹ 358 / 140
- Stock P/E
- Book Value ₹ 50.1
- Dividend Yield 0.00 %
- ROCE 28.8 %
- ROE 27.1 %
- Face Value ₹ 10.0
Pros
- Company has a good return on equity (ROE) track record: 3 Years ROE 29.5%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Working capital days have increased from 17.8 days to 75.4 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 120 | 137 | 177 | 230 | |
| 117 | 128 | 150 | 189 | |
| Operating Profit | 2 | 9 | 26 | 41 |
| OPM % | 2% | 7% | 15% | 18% |
| 0 | 0 | 1 | 2 | |
| Interest | 2 | 2 | 3 | 5 |
| Depreciation | 2 | 2 | 3 | 7 |
| Profit before tax | -1 | 5 | 21 | 32 |
| Tax % | 3% | 28% | 24% | 27% |
| -1 | 3 | 16 | 24 | |
| EPS in Rs | -0.56 | 1.68 | 8.14 | 9.07 |
| Dividend Payout % | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 24% |
| TTM: | 30% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 180% |
| TTM: | 36% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 30% |
| Last Year: | 27% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|
| Equity Capital | 20 | 20 | 20 | 24 | 24 |
| Reserves | 4 | 7 | 21 | 98 | 114 |
| 17 | 21 | 36 | 48 | 67 | |
| 41 | 49 | 41 | 40 | 68 | |
| Total Liabilities | 82 | 98 | 118 | 211 | 273 |
| 29 | 33 | 48 | 76 | 91 | |
| CWIP | 0 | 0 | 0 | 4 | 5 |
| Investments | 6 | 7 | 3 | 1 | 47 |
| 46 | 58 | 66 | 129 | 130 | |
| Total Assets | 82 | 98 | 118 | 211 | 273 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 6 | 4 | 1 | -29 | |
| -11 | -6 | -15 | -36 | |
| 3 | 2 | 16 | 67 | |
| Net Cash Flow | -1 | 0 | 2 | 2 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Debtor Days | 88 | 63 | 59 | 74 |
| Inventory Days | 46 | 71 | 96 | 126 |
| Days Payable | 185 | 251 | 102 | 102 |
| Cash Conversion Cycle | -51 | -117 | 53 | 98 |
| Working Capital Days | -11 | -21 | -1 | 75 |
| ROCE % | 16% | 37% | 29% |
Documents
Announcements
-
Analysts/Institutional Investor Meet/Con. Call Updates
16 February 2026 - Chandan Healthcare Limited has informed about Link of Recording
-
Investor Presentation
16 February 2026 - Q3/9M FY26 results; Total income ₹65.77Cr; preferential warrants ₹104.13Cr; 5-year Jeena Sikho partnership.
-
Press Release
16 February 2026 - Q3/9M FY26: 9M total income ₹203.27 Cr; EBITDA +39%; ₹104 Cr raised via warrants; ₹100 Cr expansion plan.
-
Outcome of Board Meeting
14 February 2026 - Board recorded limited review of unaudited Q3/9M results for period ended Dec 31, 2025; fund utilization certificate.
-
Analysts/Institutional Investor Meet/Con. Call Updates
10 February 2026 - Q3 & 9M FY26 earnings call on 16-Feb-2026 at 04:00 PM IST.
Business Profile[1]
Chandan Healthcare Limited operates a diagnostic network in North India that offers pathology and radiology testing services. The company has a presence in Uttar Pradesh, Uttarakhand, and Jaipur (Rajasthan), with a strong network of labs, satellite centers, and collection points